Literature DB >> 6299239

Abortive infection of neural cells by herpes simplex virus type 2.

C A Smith, G J Lancz.   

Abstract

The nature of the refractoriness of C6 rat glioma cells to herpes simplex virus type 2 (HSV-2) was examined. Infection of C6 cells with HSV-2 results in low virus yields, not exceeding the input virus. Although virus growth studies suggested a restricted cycle of virus replication, synthesis of HSV-2 DNA and HSV-2-specific antigens could not be detected. In addition, HSV-2 yields in C6 cells were unaffected by interferon, cycloheximide, tunicamycin, actinomycin D and cytosine arabinoside. However, trypsin, but not EDTA, treatment of infected C6 cells at 4 hours postinfection (p.i.) reduced maximal HSV-2 yields at 24 hours p.i. by 61 percent. These data: 1) indicate that HSV-2 fails to replicate in C6 cells and is prohibited from directing the synthesis of virus macromolecules; and 2) suggests that the increment of HSV-2 yields observed during the synthesis phase of the virus growth cycle represents re-envelopment and egress of a portion of the input virus.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6299239     DOI: 10.1007/bf01314164

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  28 in total

Review 1.  Latent herpes simplex virus and the nervous system,.

Authors:  J G Stevens
Journal:  Curr Top Microbiol Immunol       Date:  1975       Impact factor: 4.291

2.  Latent herpetic infections following experimental viraemia.

Authors:  M L Cook; J G Stevens
Journal:  J Gen Virol       Date:  1976-04       Impact factor: 3.891

3.  Herpes simplex virus infection of in vitro cultured neuronal cells (mouse neuroblastoma C 1300 cells).

Authors:  A Vahlne; E Lycke
Journal:  J Gen Virol       Date:  1978-05       Impact factor: 3.891

4.  Infection by herpes simplex virus and cells of nervous system origin: characterization of a non-permissive interaction.

Authors:  R Adler; J C Glorioso; M Levine
Journal:  J Gen Virol       Date:  1978-04       Impact factor: 3.891

5.  Persistence of herpes simplex virus type 1 in rat neurotumor cells.

Authors:  E Doller; J Aucker; A Weissbach
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

6.  Latent herpes simplex virus in spinal ganglia of mice.

Authors:  J G Stevens; M L Cook
Journal:  Science       Date:  1971-08-27       Impact factor: 47.728

7.  Viropexis of herpes simplex virus by HeLa cells.

Authors:  S Dales; H Silverberg
Journal:  Virology       Date:  1969-03       Impact factor: 3.616

8.  Electron microscopy of herpes simplex virus. I. Entry.

Authors:  C Morgan; H M Rose; B Mednis
Journal:  J Virol       Date:  1968-05       Impact factor: 5.103

9.  Herpesvirus hominis: isolation from human trigeminal ganglion.

Authors:  F O Bastian; A S Rabson; C L Yee; T S Tralka
Journal:  Science       Date:  1972-10-20       Impact factor: 47.728

10.  Differentiated rat glial cell strain in tissue culture.

Authors:  P Benda; J Lightbody; G Sato; L Levine; W Sweet
Journal:  Science       Date:  1968-07-26       Impact factor: 47.728

View more
  3 in total

1.  Thermal-pH inactivation of herpes simplex virus: interdependence of the medium composition and the pH on the rate of virus inactivation. Brief report.

Authors:  G Lancz; J Sample
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

Review 2.  The roles of viruses in brain tumor initiation and oncomodulation.

Authors:  Alexander Kofman; Lucasz Marcinkiewicz; Evan Dupart; Anton Lyshchev; Boris Martynov; Anatolii Ryndin; Elena Kotelevskaya; Jay Brown; David Schiff; Roger Abounader
Journal:  J Neurooncol       Date:  2011-07-01       Impact factor: 4.130

3.  Tankyrase inhibitor XAV-939 enhances osteoblastogenesis and mineralization of human skeletal (mesenchymal) stem cells.

Authors:  Nuha Almasoud; Nihal AlMuraikhi; Sarah Binhamdan; Ghaydaa Younis; Hanouf Alaskar; Amal Alotaibi; Muthurangan Manikandan; Musaad Alfayez; Moustapha Kassem
Journal:  Sci Rep       Date:  2020-10-07       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.